Ignite Creation Date:
2024-05-06 @ 6:44 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05761301
Status:
RECRUITING
Last Update Posted:
2024-06-27
First Post:
2023-02-24
Brief Title:
A Phase 12 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM
Sponsor:
Alnylam Pharmaceuticals
Organization:
Alnylam Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-10
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-07
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-24
First Submit QC Date:
March 7 2023
Study First Post Date:
2023-03-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-11
Last Update Post Date:
2024-06-27
Last Update Post Date Type:
ACTUAL